Home

Money

Workspace

Advice

About

Zentraxa

Zentraxa is an exciting new spin-out from the University of Bristol. They are focused on precision bioengineering to produce peptides with predictable properties, tailored to purpose.

Zentraxa is developing high-performance novel biomaterials using Zentraxa’s proprietary development and manufacturing system, Zentide®. Zentraxa’s lead biomaterial is a reversible adhesive, allowing for strong adhesion without substrate damage on removal. The company has identified two leading market niches for its lead reversible adhesive technology: topical medical adhesives, and advanced optical and sensing systems.

Website: https://zentraxa.com/

Your capital is at risk if you invest in early stage companies. These investments may not be covered by the Financial Services Compensation Scheme. Learn more about these risks<https://investment.newable.co.uk/risk-statement>. Tax advantages are dependent on an individual’s specific circumstances and subject to change.

Newable Ventures Limited (FRN 843924) is authorised and regulated by the Financial Conduct Authority. Registered in England and Wales | Registered number 10303336 | VAT number 237 9198 23 | Registered office 140 Aldersgate Street, London, EC1A 4HY. Newable Ventures Limited is registered with the Information Commissioner’s Office (ICO) with the registered Data Protection Number ZA789052.